Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

Dongsheng Yue, Wenxiang Wang, Hongxu Liu, Qixun Chen, Chun Chen, Lunxu Liu, Peng Zhang, Guofang Zhao, Fan Yang, Guang Han, Ying Cheng, Bentong Yu, Yue Yang, Haiquan Chen, Jie Jiang, Lijie Tan, Shidong Xu, Naiquan Mao, Jian Hu, Lanjun Zhang, Bin Yao, Shengfei Wang, Ruihua Wang, Wenjuan Zheng, Changli Wang, Changli Wang, Lejie Cao, Chun Chen, Fang Chen, Haiquan Chen, Jun Chen, Qixun Chen, Yuping Chen, Ying Cheng, Jiuwei Cui, Junke Fu, Guang Han, Jian Hu, Mu Hu, Yunchao Huang, Jie Jiang, Jun Li, Lin Li, Qiang Li, Shanqing Li, Yongde Liao, Changhong Liu, Hongxu Liu, Lunxu Liu, Naiquan Mao, Tiejun Ren, Yuping Sun, Lijie Tan, Min Tao, Changli Wang, Changli Wang, Wenxiang Wang, Yongsheng Wang, Jun Wu, Ming Wu, Jianping Xiong, Shidong Xu, Fan Yang, Kunpeng Yang, Yue Yang, Min Ye, Bentong Yu, Dongsheng Yue, Lanjun Zhang, Lumin Zhang, Peng Zhang, Qiudi Zhang, Yi Zhang, Guofang Zhao, Jian Zhao, Hua Zhong, Kunshou Zhu, Xibin Zhuang